HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.

Abstract

The association between HLA antigens and adverse drug reactions (ADR), (e.g. proteinuria, haematological abnormalities, stomatitis, diarrhoea and dermatitis) in rheumatoid arthritis (RA) to sodium aurothiomalate (gold) and to D-penicillamine (PA) were studied in 32 patients. Thirty-eight RA patients treated with gold and PA, and with no ADR to these drugs, were used as controls. The frequency of HLA B8 was significantly (p less than 0.05) increased among RA patients with ADR compared to plasma donors. DR3 was also significantly increased (p less than 0.05) in RA patients with haematological ADR compared to plasma donors. Haematological ADR occurred significantly (p less than 0.05) more often in DR3 positive patients (55%) than among DR3 negative RA patients (27%).

• Authors: S R Dahlqvist, H Ström, A Bjelle, E Möller
• Journal: Clinical rheumatology (Clin Rheumatol) Vol. 4 Issue 1 Pg. 55-61 (Mar 1985) ISSN: 0770-3198 [Print] Germany
• PMID: 3157529 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• HLA Antigens
• HLA-B8 Antigen
• HLA-DR3 Antigen
• Histocompatibility Antigens Class II
• Gold Sodium Thiomalate
• Penicillamine

Topics

• Adult
• Aged
• Arthritis, Rheumatoid (drug therapy, immunology)
• Diarrhea (chemically induced)
• Drug Eruptions (etiology)
• Female
• Gold Sodium Thiomalate (adverse effects, therapeutic use)
• HLA Antigens (immunology)
• HLA-B8 Antigen
• HLA-DR3 Antigen
• Histocompatibility Antigens Class II (immunology)
• Humans
• Male
• Middle Aged
• Penicillamine (adverse effects, therapeutic use)
• Proteinuria (chemically induced)
• Stomatitis (chemically induced)
• Thrombocytopenia (chemically induced)